Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 65074-65075 [2020-22690]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
65074
Federal Register / Vol. 85, No. 199 / Wednesday, October 14, 2020 / Notices
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.—These investigations
are being instituted, pursuant to section
733(a) of the Tariff Act of 1930 (19
U.S.C. 1673b(a)), in response to
petitions filed on October 7, 2020, by
Appvion Operations, Inc. (Appleton,
Wisconsin) and Domtar Corporation
(Fort Mill, South Carolina).
For further information concerning
the conduct of these investigations and
rules of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A and B (19 CFR part 207).
Participation in the investigation and
public service list.—Persons (other than
petitioners) wishing to participate in the
investigations as parties must file an
entry of appearance with the Secretary
to the Commission, as provided in
§§ 201.11 and 207.10 of the
Commission’s rules, not later than seven
days after publication of this notice in
the Federal Register. Industrial users
and (if the merchandise under
investigation is sold at the retail level)
representative consumer organizations
have the right to appear as parties in
Commission antidumping duty
investigations. The Secretary will
prepare a public service list containing
the names and addresses of all persons,
or their representatives, who are parties
to these investigations upon the
expiration of the period for filing entries
of appearance.
Limited disclosure of business
proprietary information (BPI) under an
administrative protective order (APO)
and BPI service list.—Pursuant to
§ 207.7(a) of the Commission’s rules, the
Secretary will make BPI gathered in
these investigations available to
authorized applicants representing
interested parties (as defined in 19
U.S.C. 1677(9)) who are parties to the
investigations under the APO issued in
the investigations, provided that the
application is made not later than seven
days after the publication of this notice
in the Federal Register. A separate
service list will be maintained by the
Secretary for those parties authorized to
receive BPI under the APO.
Conference.—In light of the
restrictions on access to the Commission
VerDate Sep<11>2014
19:15 Oct 13, 2020
Jkt 253001
building due to the COVID–19
pandemic, the Commission is
conducting the staff conference through
video conferencing on Wednesday,
October 28, 2020. Requests to appear at
the conference should be emailed to
preliminaryconferences@usitc.gov (DO
NOT FILE ON EDIS) on or before
Monday, October 26, 2020. Please
provide an email address for each
conference participant in the email.
Information on conference procedures
will be provided separately and
guidance on joining the video
conference will be available on the
Commission’s Daily Calendar. A
nonparty who has testimony that may
aid the Commission’s deliberations may
request permission to participate by
submitting a short statement.
Please note the Secretary’s Office will
accept only electronic filings during this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov). No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice.
Written submissions.—As provided in
§§ 201.8 and 207.15 of the
Commission’s rules, any person may
submit to the Commission on or before
November 2, 2020, a written brief
containing information and arguments
pertinent to the subject matter of the
investigations. Parties may file written
testimony in connection with their
presentation at the conference. All
written submissions must conform with
the provisions of § 201.8 of the
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of §§ 201.6, 207.3, and
207.7 of the Commission’s rules. The
Commission’s Handbook on Filing
Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf elaborates
upon the Commission’s procedures with
respect to filings.
In accordance with §§ 201.16(c) and
207.3 of the rules, each document filed
by a party to the investigations must be
served on all other parties to the
investigations (as identified by either
the public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Certification.—Pursuant to § 207.3 of
the Commission’s rules, any person
submitting information to the
Commission in connection with these
investigations must certify that the
information is accurate and complete to
the best of the submitter’s knowledge. In
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
making the certification, the submitter
will acknowledge that any information
that it submits to the Commission
during these investigations may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of these or related investigations or
reviews, or (b) in internal investigations,
audits, reviews, and evaluations relating
to the programs, personnel, and
operations of the Commission including
under 5 U.S.C. Appendix 3; or (ii) by
U.S. government employees and
contract personnel, solely for
cybersecurity purposes. All contract
personnel will sign appropriate
nondisclosure agreements.
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to § 207.12 of the
Commission’s rules.
By order of the Commission.
Issued: October 8, 2020.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2020–22658 Filed 10–13–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–718]
Bulk Manufacturer of Controlled
Substances Application: Synthcon,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Synthcon, LLC has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 14, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 14, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
SUMMARY:
E:\FR\FM\14OCN1.SGM
14OCN1
65075
Federal Register / Vol. 85, No. 199 / Wednesday, October 14, 2020 / Notices
is notice that on June 18, 2020,
Synthcon, LLC, 770 Wooten Road, Suite
101, Colorado Springs, Colorado 80915–
3538, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Drug code
Isotonitrazene ..................................................................................................................................................................
Etonitazene ......................................................................................................................................................................
Butyryl Fentanyl ...............................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .........................................
Isobutyryl fentanyl ............................................................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) .................................................................................................
The company plans to manufacture
the above-listed controlled substances
as analytical reference materials for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–22690 Filed 10–13–20; 8:45 am]
BILLING CODE P
Controlled substance
Drug
code
Schedule
Marihuana .................
7360
I
The company plans to manufacture
synthetic Cannabidiol to be distributed
as an Active Pharmaceutical Ingredient
(API) to its customers. No other activity
for these drug codes is authorized for
this registration.
William T. McDermott,
Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2020–22692 Filed 10–13–20; 8:45 am]
Drug Enforcement Administration
BILLING CODE P
[Docket No. DEA–729]
DEPARTMENT OF LABOR
Bulk Manufacturer of Controlled
Substances Application: Euticals, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Advisory Committee on Veterans’
Employment, Training and Employer
Outreach (ACVETEO): Meeting
Notice of application.
Euticals Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 14, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 14, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 21, 2020,
Euticals Inc., 2460 West Bennett Street,
Springfield, Missouri 65807–1229,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
19:15 Oct 13, 2020
Jkt 253001
Veterans’ Employment and Training
Service
Veterans’ Employment and
Training Service (VETS), Department of
Labor (DOL).
ACTION: Notice of virtual open meeting.
AGENCY:
This notice sets forth the
schedule and proposed agenda of a
forthcoming meeting of the ACVETEO.
The ACVETEO will discuss the DOL
core programs and services that assist
veterans seeking employment and raise
employer awareness as to the
advantages of hiring veterans. There
will be an opportunity for individuals or
organizations to address the committee.
Any individual or organization that
wishes to do so should contact Mr.
Gregory Green at ACVETEO@dol.gov.
Additional information regarding the
Committee, including its charter,
current membership list, annual reports,
meeting minutes, and meeting updates
may be found at https://www.dol.gov/
agencies/vets/about/advisorycommittee.
This Notice also describes the functions
of the ACVETEO. Notice of this meeting
is required under Section 10(a)(2) of the
Federal Advisory Committee Act. This
document is intended to notify the
general public.
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
9614
9624
9822
9824
9827
8366
Schedule
I
I
I
I
I
II
Wednesday, November 4, 2020
beginning at 9:00 a.m. and ending at
approximately 12:00 p.m.(EST).
ADDRESSES: This ACVETEO meeting
will be held via WebEx video and
teleconference. Meeting information
will be posted at the link below under
the Meeting Updates tab. https://
www.dol.gov/agencies/vets/about/
advisorycommittee.
Notice of Intent To Attend the
Meeting: All meeting participants
should submit a notice of intent to
attend by Monday, October 26, 2020, via
email to Mr. Gregory Green at
ACVETEO@dol.gov, subject line
‘‘November 2020 ACVETEO Meeting.’’
Individuals who will need
accommodations for a disability in order
to attend the meeting (e.g., interpreting
services, assistive listening devices,
and/or materials in alternative format)
should notify the Advisory Committee
no later than Wednesday, October 21,
2020 by contacting Mr. Gregory Green at
ACVETEO@dol.gov. Requests made after
this date will be reviewed, but
availability of the requested
accommodations cannot be guaranteed.
The meeting site is accessible to
individuals with disabilities.
FOR FURTHER INFORMATION CONTACT: Mr.
Gregory Green, Designated Federal
Official for the ACVETEO, ACVETEO@
dol.gov, (202) 693–4734.
SUPPLEMENTARY INFORMATION: The
ACVETEO is a Congressionally
mandated advisory committee
authorized under Title 38, U.S. Code,
Section 4110 and subject to the Federal
Advisory Committee Act, 5 U.S.C. App.
2, as amended. The ACVETEO is
responsible for: Assessing employment
and training needs of veterans;
determining the extent to which the
programs and activities of the U.S.
Department of Labor meet these needs;
assisting to conduct outreach to
employers seeking to hire veterans;
making recommendations to the
Secretary, through the Assistant
Secretary for Veterans’ Employment and
Training Service, with respect to
outreach activities and employment and
training needs of veterans; and carrying
out such other activities necessary to
DATES:
E:\FR\FM\14OCN1.SGM
14OCN1
]]>Agencies
[Federal Register Volume 85, Number 199 (Wednesday, October 14, 2020)]
[Notices]
[Pages 65074-65075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22690]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-718]
Bulk Manufacturer of Controlled Substances Application: Synthcon,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Synthcon, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 14,
2020. Such persons may also file a written request for a hearing on the
application on or before December 14, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
[[Page 65075]]
is notice that on June 18, 2020, Synthcon, LLC, 770 Wooten Road, Suite
101, Colorado Springs, Colorado 80915-3538, applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Isotonitrazene........................... 9614 I
Etonitazene.............................. 9624 I
Butyryl Fentanyl......................... 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
Isobutyryl fentanyl...................... 9827 I
Norfentanyl (N-phenyl-N-(piperidin-4-yl) 8366 II
propionamide).
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances as analytical reference materials for distribution to its
customers. No other activities for these drug codes are authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22690 Filed 10-13-20; 8:45 am]
BILLING CODE P
